ADiag: Graph Neural Network Based Diagnosis of Alzheimer's Disease

• URL: http://arxiv.org/abs/2101.02870v1
• Date: Fri, 8 Jan 2021 06:23:30 GMT
• Title: ADiag: Graph Neural Network Based Diagnosis of Alzheimer's Disease
• Authors: Vishnu Ram Sampathkumar
• Abstract summary: Alzheimer's Disease (AD) is the most widespread neurodegenerative disease, affecting over 50 million people across the world. Currently, only qualitative means of testing are employed in the form of scoring performance on a battery of cognitive tests. We have developed ADiag, a novel quantitative method to diagnose AD through GraphSAGE Network and Dense Differentiable Pooling (DDP) analysis. Preliminary tests of ADiag have revealed a robust accuracy of 83%, vastly outperforming other qualitative and quantitative diagnostic techniques.
• Score: 0.0
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Alzheimer's Disease (AD) is the most widespread neurodegenerative disease, affecting over 50 million people across the world. While its progression cannot be stopped, early and accurate diagnostic testing can drastically improve quality of life in patients. Currently, only qualitative means of testing are employed in the form of scoring performance on a battery of cognitive tests. The inherent disadvantage of this method is that the burden of an accurate diagnosis falls on the clinician's competence. Quantitative methods like MRI scan assessment are inaccurate at best,due to the elusive nature of visually observable changes in the brain. In lieu of these disadvantages to extant methods of AD diagnosis, we have developed ADiag, a novel quantitative method to diagnose AD through GraphSAGE Network and Dense Differentiable Pooling (DDP) analysis of large graphs based on thickness difference between different structural regions of the cortex. Preliminary tests of ADiag have revealed a robust accuracy of 83%, vastly outperforming other qualitative and quantitative diagnostic techniques.

Related papers

• MINDSETS: Multi-omics Integration with Neuroimaging for Dementia Subtyping and Effective Temporal Study [0.7751705157998379]
  Alzheimer's disease (AD) and vascular dementia (VaD) are the two most prevalent dementia types. This paper presents an innovative multi-omics approach to accurately differentiate AD from VaD, achieving a diagnostic accuracy of 89.25%.
  arXiv  Detail & Related papers  (2024-11-06T10:13:28Z)
• Towards Within-Class Variation in Alzheimer's Disease Detection from Spontaneous Speech [60.08015780474457]
  Alzheimer's Disease (AD) detection has emerged as a promising research area that employs machine learning classification models. We identify within-class variation as a critical challenge in AD detection: individuals with AD exhibit a spectrum of cognitive impairments. We propose two novel methods: Soft Target Distillation (SoTD) and Instance-level Re-balancing (InRe), targeting two problems respectively.
  arXiv  Detail & Related papers  (2024-09-22T02:06:05Z)
• A Survey of Artificial Intelligence in Gait-Based Neurodegenerative Disease Diagnosis [51.07114445705692]
  neurodegenerative diseases (NDs) traditionally require extensive healthcare resources and human effort for medical diagnosis and monitoring. As a crucial disease-related motor symptom, human gait can be exploited to characterize different NDs. The current advances in artificial intelligence (AI) models enable automatic gait analysis for NDs identification and classification.
  arXiv  Detail & Related papers  (2024-05-21T06:44:40Z)
• Evaluating Echo State Network for Parkinson's Disease Prediction using Voice Features [1.2289361708127877]
  This study aims to develop a diagnostic model capable of achieving both high accuracy and minimizing false negatives. Various machine learning methods, including Echo State Networks (ESN), Random Forest, k-nearest Neighbors, Support Vector, Extreme Gradient Boosting, and Decision Tree, are employed and thoroughly evaluated. ESN consistently maintains a false negative rate of less than 8% in 83% of cases.
  arXiv  Detail & Related papers  (2024-01-28T14:39:43Z)
• A Foundational Framework and Methodology for Personalized Early and Timely Diagnosis [84.6348989654916]
  We propose the first foundational framework for early and timely diagnosis. It builds on decision-theoretic approaches to outline the diagnosis process. It integrates machine learning and statistical methodology for estimating the optimal personalized diagnostic path.
  arXiv  Detail & Related papers  (2023-11-26T14:42:31Z)
• BMAD: Benchmarks for Medical Anomaly Detection [51.22159321912891]
  Anomaly detection (AD) is a fundamental research problem in machine learning and computer vision. In medical imaging, AD is especially vital for detecting and diagnosing anomalies that may indicate rare diseases or conditions. We introduce a comprehensive evaluation benchmark for assessing anomaly detection methods on medical images.
  arXiv  Detail & Related papers  (2023-06-20T20:23:46Z)
• LAVA: Granular Neuron-Level Explainable AI for Alzheimer's Disease Assessment from Fundus Images [15.02513291695459]
  Alzheimer's Disease (AD) is a progressive neurodegenerative disease and the leading cause of dementia. The retina has been hypothesized as a diagnostic site for AD detection owing to its anatomical connection with the brain. We propose a novel model-agnostic explainable-AI framework, called Granular Neuron-level Explainer (LAVA)
  arXiv  Detail & Related papers  (2023-02-06T18:43:10Z)
• NeuralSympCheck: A Symptom Checking and Disease Diagnostic Neural Model with Logic Regularization [59.15047491202254]
  symptom checking systems inquire users for their symptoms and perform a rapid and affordable medical assessment of their condition. We propose a new approach based on the supervised learning of neural models with logic regularization. Our experiments show that the proposed approach outperforms the best existing methods in the accuracy of diagnosis when the number of diagnoses and symptoms is large.
  arXiv  Detail & Related papers  (2022-06-02T07:57:17Z)
• Deep Convolutional Neural Network based Classification of Alzheimer's Disease using MRI data [8.609787905151563]
  Alzheimer's disease (AD) is a progressive and incurable neurodegenerative disease which destroys brain cells and causes loss to patient's memory. In this paper, we have proposed a smart and accurate way of diagnosing AD based on a two-dimensional deep convolutional neural network (2D-DCNN) using imbalanced three-dimensional MRI dataset. The model classifies MRI into three categories: AD, mild cognitive impairment, and normal control: and has achieved 99.89% classification accuracy with imbalanced classes.
  arXiv  Detail & Related papers  (2021-01-08T06:51:08Z)
• Application of Machine Learning to Predict the Risk of Alzheimer's Disease: An Accurate and Practical Solution for Early Diagnostics [1.1470070927586016]
  Alzheimer's Disease (AD) ravages the cognitive ability of more than 5 million Americans and creates an enormous strain on the health care system. This paper proposes a machine learning predictive model for AD development without medical imaging and with fewer clinical visits and tests. Our model is trained and validated using demographic, biomarker and cognitive test data from two prominent research studies.
  arXiv  Detail & Related papers  (2020-06-02T14:52:51Z)
• A Graph Gaussian Embedding Method for Predicting Alzheimer's Disease Progression with MEG Brain Networks [59.15734147867412]
  Characterizing the subtle changes of functional brain networks associated with Alzheimer's disease (AD) is important for early diagnosis and prediction of disease progression. We developed a new deep learning method, termed multiple graph Gaussian embedding model (MG2G) We used MG2G to detect the intrinsic latent dimensionality of MEG brain networks, predict the progression of patients with mild cognitive impairment (MCI) to AD, and identify brain regions with network alterations related to MCI.
  arXiv  Detail & Related papers  (2020-05-08T02:29:24Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.